In this retrospective study involving women with uterine cervix cancer residing in or near Appalachian Kentucky, a significantly higher proportion (60%) of women with adenocarcinomas than squamous cell carcinomas (4%) had positive HER2 immunohistochemistry. The gene discussed is ERBB2; the disease is adenocarcinoma.